Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Fixed Capital/Sales

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2013Mar2012
   Fixed Capital/Sales(x) 0.820.890.620.480.45

What is the latest Fixed Capital/Sales ratio of NATH BIOGENES (INDIA) ?

The latest Fixed Capital/Sales ratio of NATH BIOGENES (INDIA) is 0.82 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.82
Mar20230.89
Mar20220.62
Mar20130.48
Mar20120.45

How is Fixed Capital/Sales of NATH BIOGENES (INDIA) Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.82
-7.87
Mar2023 0.89
43.55
Mar2022 0.62
29.17
Mar2013 0.48
6.67
Mar2012 0.45 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Fixed Capital/Sales ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹378.5 Cr 9.4% 6.2% -4.6% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹16,666.8 Cr -5.1% -12.2% 71.1% Stock Analytics
KAVERI SEED COMPANY ₹4,594.5 Cr 0.7% 1.5% 47.5% Stock Analytics
VENKYS (INDIA) ₹2,459.5 Cr 2.5% -2.7% -13.1% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,711.1 Cr 12.7% -1.8% -21.8% Stock Analytics
TIERRA AGROTECH ₹402.5 Cr -0% 0.8% -34.1% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

9.4%

6.2%

-4.6%

SENSEX

0.2%

-0.2%

21.6%


You may also like the below Video Courses